There is also the use of targeted delivery systems, including prostate‐specific membrane antigen (PSMA)‐specific micelles, which can specifically target wogonin into prostate cancer cells, causing apoptosis that has a low impact on systemic toxicity (Zhang et al. 2016). Here, FOLH1 is linked to prostate cancer.